IMmotion151 compared therapy with atezolizumab, a monoclonal anti-body of IgG1 isotype against PD-L1, and bevacizumab, an anti-VEGF monoclonal antibody approved to treat many cancer types, with sunitinib.
A phase 2 trial demonstrates promising results in patients with glioblastoma who take SurVaxM, an immunotherapy vaccine that targets survivin.
Cleveland Clinic researchers present study at DDW 2018 which found that measuring intracystic glucose levels was more accurate than current testing protocols for distinguishing between precancel mucinous cysts and benign nonmutinous cysts.
People with a higher incidence of cancer — multiple melanomas, melanoma and additional cancers or a family history of melanomas and other malignancies — can carry a higher risk for breast, pros-tate, brain and other cancers.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Results of a multi-institutional phase 1b clinical trial show women with metastatic HER2+ breast cancer respond well to the combina-tion of trastuzumab emtansine and neratinib.
Cleveland Clinic researchers are part of a new effort to generate prospective clinical genomics that inform treatment decisions in patients with glioblastoma
Current guidelines recommend exercise stress echo, but it can’t reliably detect significant obstructive CAD in patients with LBBB at rest. We share nuanced recommendations for alternatives.
Robotic RPP offers a variety of advantages for surgeon and patient, especially more direct access to the prostate. It’s gaining traction in the U.S. and has now debuted in Europe.
The CEO of Cleveland Clinic Florida argues that healthcare costs should not cause undue hardship, and reflects on the ethical responsibilities of physicians.
Cognition-enhancing drugs and psychotropic drugs for behavioral symptoms of Alzheimer disease need to be continuously evaluated for clinical efficacy.